Knight, Adam L <br/><br/>
The glycolytic enzyme, GPI, is a functionally conserved modifier of dopaminergic neurodegeneration in Parkinson's models.  [electronic resource] 

 -  Cell metabolism  Jul 2014 
 - 145-57 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-7420 
<br/><br/><label>Standard No.: </label>10.1016/j.cmet.2014.04.017  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aging<br/>Animals<br/>Caenorhabditis elegans--metabolism<br/>Caenorhabditis elegans Proteins--antagonists & inhibitors<br/>Cells, Cultured<br/>Cytokines--antagonists & inhibitors<br/>Disease Models, Animal<br/>Dopaminergic Neurons--cytology<br/>Drosophila--metabolism<br/>Drosophila Proteins--antagonists & inhibitors<br/>Forkhead Transcription Factors--metabolism<br/>Glucose--metabolism<br/>Glucose-6-Phosphate Isomerase--antagonists & inhibitors<br/>Glycolysis<br/>Insulin Receptor Substrate Proteins--genetics<br/>Insulin-Like Growth Factor I--metabolism<br/>Male<br/>Mice<br/>Parkinson Disease--metabolism<br/>RNA Interference<br/>RNA, Small Interfering--metabolism<br/>Receptor, Insulin--antagonists & inhibitors<br/>Signal Transduction<br/>Transcription Factors--antagonists & inhibitors<br/>alpha-Synuclein--chemistry